Abstract
Tumors in the maxillofacial region can arise in the soft and hard tissues. Those located in the facial skeleton are rare and can be of odontogenic or osseous origin. No matter whether they are benign or malignant, clinically they are often symptomless for a long time. Even radiologically, their appearance is mostly uniform and lytic. Most lesions expand the jawbones over time, and patients notice painless swellings or facial deformity. Size generally does not help in the differential diagnosis. Delineation, intralesional matrix mineralization and the exact site of origin on the other hand are important clues to the correct diagnosis [1–3]. Although computed tomography (CT) or magnetic resonance imaging (MRI) is much more precise in characterizing the content and delineation of tumors, in most cases it is not possible to establish a diagnosis without biopsy and histologic examination. Biopsies should always be obtained as open biopsies to receive sufficient material in quantity and quality. This is particularly important since some lesions can present histologically similar or can be affected by metaplastic changes due to secondary inflammation which can blur the diagnostic hallmarks. The key to an adequate diagnosis is a close interdisciplinary collaboration between the clinician, the pathologist, and the radiologist. The treatment plan is, of course, crucially dependent on a precise preoperative diagnosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baumhoer D, Lopes M, Raubenheimer E. Osteosarcoma. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO Classification of Head and Neck Tumours. Lyon, France: IARC Press; 2017. p. 244–6.
El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO Classification of Head and Neck Tumours. Lyon, France: IARC Press; 2017.
Park HY, Yang SK, Sheppard WL, Hegde V, Zoller SD, Nelson SD, Federman N, Bernthal NM. Current management of aneurysmal bone cysts. Curr Rev Musculoskelet Med. 2016;9:435–44.
Speight PM, Takata T. New tumour entities in the 4th edition of the World Health Organization Classification of Head and Neck Tumours: Odontogenic and Maxillofacial Bone Tumours. Virchows Arch. 2017.
Parmar S, Al-Qamachi L, Aga H. Ameloblastomas of the mandible and maxilla. Curr Opin Otolaryngol Head Neck Surg. 2016;24:148–54.
Sweeney RT, McClary AC, Myers BR, Biscocho J, Neahring L, Kwei KA, Qu K, Gong X, Ng T, Jones CD, Varma S, Odegaard JI, Sugiyama T, Koyota S, Rubin BP, Troxell ML, Pelham RJ, Zehnder JL, Beachy PA, Pollack JR, West RB. Identification of recurrent SMO and BRAF mutations in ameloblastomas. Nat Genet. 2014;46(7):722–5.
Vered M, Muller S, Heikinheimo K. Ameloblastoma. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO Classification of Head and Neck Tumours. Lyon, France: IARC Press; 2017. p. 215–7.
Presneau N, Baumhoer D, Behjati S, Pillay N, Tarpey P, Campbell PJ, Jundt G, Hamoudi R, Wedge DC, Loo PV, Hassan AB, Khatri B, Ye H, Tirabosco R, Amary MF, Flanagan AM. Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimics. J Pathol Clin Res. 2015;1(2):113–23.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this chapter
Cite this chapter
Baumhoer, D., Prein, J., Schmelzeisen, R. (2019). Tumors of the Maxillofacial Bones and Considerations for Bone Invasion. In: Greenberg, A., Schmelzeisen, R. (eds) Craniomaxillofacial Reconstructive and Corrective Bone Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1529-3_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1529-3_7
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1528-6
Online ISBN: 978-1-4939-1529-3
eBook Packages: MedicineMedicine (R0)